Ito T, Suno M, Shintani M, Iwata A, Fujii T, Matsubara K. Simultaneous quantification of filgotinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry: validation and clinical application. Biomed Chromatogr, 39(4): e70030 (2025)
Kitahiro Y, Hashimoto M, Sonda Y, Yagi M, Itohara K, Kido T, Fujioka K, Imafuku H, Omura T, Yano I. Neonatal metabolic alkalosis and mild diuresis resulting from torasemide self-medication by the mother: a case report. J Pharm Health Care Sci, 11(1):31 (2025)
Nishio M, Yamaguchi K, Otani J, Yuguchi K, Kohno D, Sasaki T, Kitamura T, Shinohara M, Soga T, Kawamura K, Sasaki AT, Oshima M, Hikasa H, Woo M, Sasaki T, Nishina H, Nakao K, Maehama T, Suzuki A. MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes. Proc Natl Acad Sci U S A. 122(17): e2424741122 (2025).
Itohara K, Yamamoto K, Fujinaka S, Hashimoto M, Tamura N, Kitahiro Y, Omura T, Fujioka K, Yano I. Pharmacokinetic and Pharmacodynamic Assessment of Valganciclovir in Infants With Congenital Cytomegalovirus Infection. Ther Drug Monit, 47(3):393-399 (2025)
Morio K, Iwai C, Yasuda S, Kawashiri T, Hidaka N, Suzuki A, Uchida M, Takase H. Nationwide survey of pharmacist involvement in managing cancer pain in children. J Nippon Med Sch 92 (4):337-348 (2025)
Kimura T, Hikasa S, Ishihara M, Tsukiji M, Kunimoto Y, Nobori K, Onishi K, Yamamoto Y, Haruta K, Kashiwabara Y, Fujii K, Yamamoto K, Omura T, Ebisawa K, Ohji G, Iwata K, Yano I. Treatment satisfaction and needs among people living with HIV who have incomplete viral load suppression in Japan: A multicenter, cross-sectional, observational study. J Infect Chemother, 31(6):102711 (2025)
Tamura N, Itohara K, Ueda Y, Kitahiro Y, Yamamoto K, Omura T, Sakane T, Saegusa J, Yano I. Optimization of Preemptive Therapy for Cytomegalovirus Infections With Valganciclovir Based on Therapeutic Drug Monitoring: Protocol for a Phase II, Single-Center, Single-Arm Trial. JMIR Res Protoc, 14: e72549 (2025)
Kakei Y, Kitahiro Y, Ioroi T, Kashin M, Kobayashi M, Morioka A, Yamamoto K, Hasegawa T, Yano I, Akashi M. Efficacy of Ibuprofen Gargle for Oral Lichen Planus: A Single-Center, Placebo-Controlled, Double-Blind, Randomized Crossover Study Trial. Cureus, 17(8): e91242 (2025)
Hori T, Yamamoto K, Nakagawa T, Nakagawa R, Okayama M, Sudou T, Hamasaki M, Yasuda M, Kobayashi S, Nakamura F, Yagi H, Kitahiro Y, Ikushima S, Yano I. Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions. Int J Hematol, 122(3):413-420 (2025)
Tokunaga E, Inoue J, Asaji N, Oyama K, Soga A, Shimamoto Y, Kinoshita M, Tanaka T, Hayashi H, Ikegawa T, Ito Y, Ikeda S, Okamoto N, Miyazaki H, Ku Y, Watanabe D, Ooi M, Hoshi N, Makimoto H, Yano I, Umegaki E, Kodama Y. Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study. Sci Rep, 15(1):32085 (2025)
Ito T, Yamashita S, Suno M, Iwata A, Kohjimoto Y, Matsubara K. Effect of hemodialysis on total and free lenvatinib concentrations in a patient with metastatic renal cell carcinoma. IJU Case Rep, 8(6):601-603 (2025)
Hori T, Yamamoto K, Ito T, Ikushima S, Omura T, Yano I. Neutrophil-to-lymphocyte ratio affects the impact of proton pump inhibitors on efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer. Int J Clin Oncol, 30(11):2266-2276 (2025)
Mahdy WYB, Yamamoto K, Joji R, Hashimoto M, Nakasone R, Fujioka K, Itohara K, Kitahiro Y, Omura T, Yano I. Evaluation of Fentanyl-Emerged Adverse Events and Pharmacokinetics in Neonates: A Physiologically Based Pharmacokinetic Modeling Approach. Clin Pharmacokinet, 64(12):1811-1825 (2025)
Ito T, Itohara K, Hirata S, Kimura T, Kitahiro Y, Omura T, Kotani J, Yano I. Impact of continuous hemodiafiltration on serum acyclovir concentrations in a patient with encephalopathy. J Infect Chemother, 31(12):102859 (2025)
Iida M, Mori M, Ikari T, Suzuki K, Tanaka-Yagi Y, Watanabe H, Ohmori T, Matsumoto Y, Yamaguchi T. Analysis of systemic opioid prescribing patterns for dyspnea in opioid-naive cancer patients: a secondary analysis of a multicenter observational study in Japan. Support Care Cancer, 34(1):53 (2025)
Omura T, Nishiguchi H, Kaneda H, Kitahiro Y, Itohara K, Yamamoto K, Sakane T, Yano I. Plasma expression levels of microRNA-101 are downregulated in patients with Parkinson’s disease. BMC Research Notes,19:19 (2026)
Kitahiro Y, Kakei Y, Ioroi T, Yatagai N, Kashin M, Kobayashi M, Morioka A, Yamamoto K, Hasegawa T, Akashi M, Yano I. Ibuprofen gargle for quality of life and pain improvement in oral lichen planus: randomized crossover and long-term extension phase II study. J Pharm Health Care Sci, 12(14):1-9 (2026)
Kimura T, Yamamoto K, Saeki R, Omura T, Yano I. Impact of the Medical Policy Intervention for Polypharmacy on Long-Term Prescriptions of Hypnotic Medications in Older Patients: An Interrupted Time-Series Analysis Using a Nationwide Claims Database in Japan. Geriatr Gerontol Int, 26(2): e70376 (2026)
Tamura N, Itohara K, Kouyama S, Kitahiro Y, Yamamoto K, Omura T, Sakane T, Saegusa J, Yano I. Development and Validation of a Liquid Chromatograph-Tandem Mass Spectrometry Method for Quantifying Ganciclovir in Dried Blood Spots for Therapeutic Drug Monitoring. Biomed Chromatgr, 40(4): e70411 (2026)
Konishi Y, Omura T, Ijichi T, Nishiguchi H, Hayakawa R, Kitahiro Y, Itohara K, Yamamoto K, Yano I. Bortezomib induces apoptosis via upregulation of Abhd4 in peripheral nerve cells. Biol Pharm Bul.,49(3):496-502 (2026)
Itohara K, Fujita K, Kitahiro Y, Fujiwara N, Konishi T, Hashimoto M, Yamamoto K, Omura T, Yano I: PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL ANALYSIS OF ANTIPSYCHOTICS BEFORE AND AFTER CHILDBIRTH, ASCPT 2025 Annual Meeting, May 2025, Washington, D.C.
Omura T, Nomura L, Nishiguchi H, Kaneda H, Kitahiro Y, Itohara K, Tanaka A, Furubayashi T, Yamamoto K, Sakane T, Matsubara K, Yano I. MICRORNA REGULATING SEL1L INVOLVED IN THE PATHOGENESIS OF PARKINSON’S DISEASE AND ITS EXPRESSION LEVELS IN PATIENT PLASMA. ASCPT 2025 Annual Meeting, May 2025, Washington, D.C.
Hikasa S, Ishihara M, Tsukiji M, Kunimoto Y, Nobori K, Kimura T, Yamamoto Y, Haruta K, Kasiwabara Y, Fujii K, Kimura T: Anticholinergic Burden Among Japanese People Living with HIV Receiving Antiretroviral Therapy: A Multicenter Cross-Sectional Study, Asia Pacific AIDS and Co-Infections Conference (APACC) 2025, June 2025, Tokyo
Tsukiji M, Hikasa S, Ishihara M, Kunimoto Y, Nobori K, Kimura T, Yamamoto Y, Haruta K, Kasiwabara Y, Fujii K, Yamazaki S, Niitsu T, Igari H, Ishii I: Potential Demand for Antiretroviral Therapy in People with HIV who have Depressive and Anxiety Symptoms: A Multicenter Cross-sectional Study in Japan., Asia Pacific AIDS and Co-Infections Conference (APACC) 2025, June 2025, Tokyo
Nakamura T, Yamashita K, Nishida S, Iwanaga K, Yamamoto K, Yano I. Evaluation of isotope effect in blood concentrations of zinc and copper after cisplatin-based chemotherapy. ISSX2025, September 2025, Chicago
Cao J, Hira D, Kotani K, Wildschut AC, Takahashi R, Katada Y, Umemura K, Hirai M, Katsube Y, Itohara K, Nakagawa S, Nakajima D, Ito T, Kanda J, Date H, Hatano E, Takaori-Kondo A, Terada T: Applicability of pharmacogenomics panel in clinical quantitative prediction of drug-drug interactions in transplant patients receiving multiple medications, 第35回日本医療薬学会年会, 2025年11月, 兵庫
Ito T, Yamashita S, Iwata A, Shintani M, Okuda A, Sakai H, Kohjimoto Y, Matsubara K, Suno M: Effect of hemodialysis on total and free lenvatinib concentrations in a patient with metastatic renal cell carcinoma, 第35回日本医療薬学会年会, 2025年11月, 兵庫
Kimura T, Saeki S, Yamamoto K, Omura T, Yano I: Impact of the medical fee revisions related to polypharmacy in Japan on long-term prescriptions of hypnotic medications in aged patients: An interrupted time series analysis using real-world data., The 35th Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences, 2025年11月, 兵庫
Kakei Y, Ioroi T, Miyakoda K, Ito T, Kashin M, Shirai T, Hasegawa T, Sakane T, Yano I. Akashi M. Assessment of Patient Characteristics Influencing the Analgesic Effects of Ibuprofen Gargle After Mandibular Third Molar Extractions. Cureus, 16(4): e57516 (2024)
Kunimoto Y, Hikasa S, Ishihara M, Tsukiji M, Nobori K, Kimura T, Onishi K, Yamamoto Y, Haruta K, Kasiwabara Y, Fujii K, Fukudo M. Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV. J Pharm Health Care Sci, 10(1):27 (2024)
HoriT, YamamotoK, ItoT, Ikushima S, OmuraT, YanoI. Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-mutated non-small cell lung cancer. Investigational New Drugs,42(3): 281-288 (2024)
Tomida T, Kimura T, Yamamoto K, Uda A, Matsumoto Y, Tamura N, Iida M, Tanifuji A, Matsumoto K, Mizuta N, Ebisawa K, Ohji G, Omura T, Iwata K, Yano I. Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study. J Pharm Health Care Sci, 10(1):54 (2024)
Konishi T, Kitahiro Y, Fujiwara N, Yamamoto K, Hashimoto M, Ito T, Itohara K, Fujioka K, Imafuku H, Otsuka I, Omura T, Yano I. Pharmacokinetics of Brexpiprazole, Quetiapine, Risperidone, and Its Active Metabolite Paliperidone in a Postpartum Woman and Her Baby. Ther Drug Monit, 46(5):687-691 (2024)
Kakei Y, Morioka I, Imai T, Itohara K, Yano I, Takahashi N, Yoshikawa T, Moriuchi H, Ito Y, Fujioka K, Oka A. Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease. J Infect Chemother, 30(10):971-977 (2024)
Kurimura T, Omura T, Yamamoto K, Tanaka H, Kimura T, Itohara K, Kitahiro Y, Habu Y, Sakane T, Yano I. Prolonged Prothrombin Time due to Drug-Drug Interaction of Warfarin after the Change from Bosentan to Macitentan: A Case of Pharmacist Intervention in the Outpatient Clinic. Kobe J Med Sci, 70(4): E125-E129 (2025)
Takahashi R, Itohara K, Nakagawa S, Katada Y, Sugimoto M, Umemura K, Matsumura K, Hira D, Tsuda M, Katsube Y, Tanaka S, Ohsumi A, Nakajima D, Nagao M, Date H, Terada T. Model-Informed Dosing Optimization of Tacrolimus for Concomitant Administration With Itraconazole to Japanese Lung Transplant Recipients. Ther Drug Monit, 47(2):248-257 (2025)
Kitahiro Y, Konishi T, Fujiwara N, Yamamoto K, Hashimoto M, Ito T, Itohara K, Fujioka K, Imafuku H, Otsuka I, Omura T, Yano I: Pharmacokinetics of brexpiprazole, quetiapine, risperidone, and its active metabolite paliperidone in perinatal period: A case study, 第34回日本医療薬学会年会, 2024年11月, 千葉
Nishiguchi H, Omura T, Sato A, Kitahiro Y, Yamamoto K, Itohara K, Kunimasa J, Yano I.: "Luteolin protects against neuronal cell death in cellular model of Parkinson’s disease via an upregulation of HRD1 and SEL1L," 第34回日本医療薬学会年会, 2024年11月, 千葉
Tanda M, Yamamoto K, Hori T, Nishiguchi H, Yagi M, Shimizu M, Konishi T, Ozaki T, Yoshioka N, Tachihara M, Ito T, Ikushima S, Omura T, Yano I. Association of STAT3, CYP3A5, and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients. Anticancer Res, 43 (4): 1775-1783 (2023)
Mahdy WYB, Yamamoto K, Ito T, Fujiwara N, Fujioka K, Horai T, Otsuka I, Imafuku H, Omura T, Iijima K, Yano I. Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate. Clin Transl Sci, 16 (4): 618-630 (2023)
Fujimoto T, Hyodo Y, Ishimura T, Tashiro Y, Endo T, Nisioka S, Yokoyama N, Yamamoto K, Yano I, Fujisawa M. Association of alpha-actinin-3 polymorphism with sarcopenia in kidney transplant recipients. Transplant Proc, 55 (4): 824-828 (2023)
Hori T, Yamamoto K, Ito T, Ikushima S, Omura T, Yano I. Upfront Use of First-/Second-Generation EGFR-TKI Followed by Osimertinib Shows Better Prognosis than Upfront Osimertinib Therapy in Japanese Patients with Non-small-cell Lung Cancer with Exon 19 Deletion: A Single-Center Retrospective Study. Biol Pharm Bull, 46 (6): 788-795 (2023)
Masui S, Yonezawa A, Nakamura M, Onishi A, Hashimoto M, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Yokoyama K, Iwamoto N, Shimada T, Itohara K, Hira D, Nakagawa S, Imai S, Nakagawa T, Hayakari M, Matsuda S, Morinobu A, Terada T, Matsubara K. Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis. Biol Pharm Bull, 46 (8): 1112-1119 (2023)
Ishihara M, Hikasa S, Tsukiji M, Kunimoto Y, Nobori K, Kimura T, Onishi K, Yamamoto Y, Haruta K, Kashiwabara Y, Fujii K, Shimabukuro S, Watanabe D, Tsurumi H, Suzuki A. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study. AIDS Res Ther, 20 (1): 62 (2023)
Kurimura T, Yamamoto K, Tanaka H, Toba T, Kimura T, Habu Y, Itohara K, Kitahiro Y, Omura T, Yano I. Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study. J Pharm Health Care Sci, 9 (1): 28 (2023)
Mizutani Y, Kawamoto S, Takahashi M, Doi H, Wakida K, Tabuchi S, Tanda M, Soga A, Chijiki R, Takakura H, Kawaguchi K, Higashime A, Watanabe M, Ichikawa H, Matsumoto S, Sakai R, Goto H, Kurata K, Kakiuchi S, Miyata Y, Uryu K, Inui Y, Kitao A, Yakushijin K, Matsuoka H, Minami H. Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study. Intern Med, 62 (20): 2949-2958 (2023)
Nakayama Y, Enomoto D, Yamamoto K, Takara K. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus. Anticancer Res, 43 (10): 4349-4357 (2023)
Ioroi T, Kakei Y, Ito T, Shirai T, Okazaki Y, Hasegawa T, Akashi M, Yano I. Efficacy and safety of ibuprofen gargle for postoperative pain after mandibular third molar extraction: A phase II, placebo-controlled, double-blind, randomized crossover trial. Clin Exp Dent Res, 9 (6): 1058-1068 (2023)
Katada Y, Nakagawa S, Nagao M, Umemura K, Itohara K, Nishikawa A, Hashi S, Katsube Y, Hira D, Ohsumi A, Nakajima D, Date H, Terada T. Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis. Transpl Infect Dis, 25 (6): e14141 (2023)
Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, Kitahiro Y, Yokoyama N, Hyodo Y, Omura T, Yano I. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug Metab Pharmacokinet, 53: 100529 (2023)
Nishiguchi H, Omura T, Sato A, Kitahiro Y, Yamamoto K, Kunimasa J, Yano I. Luteolin protects against 6-hydoroxydopamine-induced cell death via an upregulation of HRD1 and SEL1L. Neurochem Res, 49 (1): 117-128 (2024)
Kitahiro Y, Yamamoto K, Yakushijin K, Ioroi T, Tanda M, Itohara K, Omura T, Minami H, Yano I. The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial. JMIR Res Protoc, 13: e54882 (2024)
Sakaue T, Yamamoto K, Itohara K, Kitahiro Y, Endo T, Yokoyama N, Ishimura T, Omura T, Yano I. Population pharmacokinetics of everolimus in renal transplant recipients receiving long-term multiple immunosuppressive therapy. Drug Metab Pharmacokinet. 56: 101009 (2024)
Nishikawa A, Ito I, Yonezawa A, Itohara K, Matsubara T, Sato Y, Matsumura K, Hamada S, Tanabe N, Kai S, Imoto E, Yoshikawa K, Ohtsuru S, Yanagita M, Hirai T, Terada T. Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series. J Infect Chemother, 30 (4): 348-351 (2024)
Kawata M, Yonezawa A, Mineharu Y, Itohara K, Mizota T, Matsui Y, Kikuchi T, Yamao Y, Hattori EY, Hamada M, Hira D, Furukawa K, Miyamoto S, Terada T, Matsubara K, Arakawa Y. Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations. Sci Rep, 14 (1): 6326 (2024)
Muto S, Matsubara T, Inoue T, Kitamura H, Yamamoto K, Ishii T, Yazawa M, Yamamoto R, Okada N, Mori K, Yamada H, Kuwabara T, Yonezawa A, Fujimaru T, Kawano H, Yokoi H, Doi K, Hoshino J, Yanagita M． Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022． Int J Clin Oncol, 28(10):1259-1297 (2023)
Nishiyama H, Inoue T, Koizumi Y, Kobayashi Y, Kitamura H, Yamamoto K, Takeda T, Yamamoto T, Yamamoto R, Matsubara T, Hoshino J, Yanagita M; committee of Clinical practice guidelines for the management of kidney disease during anticancer drug therapy 2022． Chapter 2: indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022． Int J Clin Oncol, 28(10):1298-1314 (2023)
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, Fujiwara Y, Hanafusa N, Hatta T, Hoshino J, Ichioka S, Inoue T, Ishikura K, Kato T, Kitamura H, Kobayashi Y, Koizumi Y, Kondoh C, Matsubara T, Matsubara K, Matsumoto K, Okuda Y, Okumura Y, Sakaida E, Shibagaki Y, Shimodaira H, Takano N, Uchida A, Yakushijin K, Yamamoto T, Yamamoto K, Yasuda Y, Oya M, Okada H, Nangaku M, Kashihara N． Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022． Clin Exp Nephrol, 28(2):85-122 (2024)
2023年度日本医療薬学会 JPHCS誌論文賞：木村丈司,藤田美佐,清水倫子,住吉霞美,番匠咲帆,山本和宏,大村友博,矢野育子：Effectiveness of pharmacist intervention for deprescribing potentially inappropriate medications: a prospective observational study,” J Pharm Health Care Sci, 8 (1): 12 (2022)
第33回日本医療薬学会年会 優秀演題賞（International Session）：Hori T, Yamamoto K, Ito T, Ikushima S, Itohara K, Kitahiro Y, Omura T, Yano I: Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-positive non-small cell lung cancer.
Yamamoto K, Mahdy WYB, Hashimoto M, Hasegawa M, Nakasone R, Fujioka K, Itohara K, Kitahiro Y, Omura T, Yano I: Physiologically-based pharmacokinetic modeling and simulation of fentanyl for treatment optimization in neonates, The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023), September 2023, Oslo．
Itohara K, Tomida T, Yamamoto K, Kimura T, Fujita K, Uda A, Kitahiro Y, Yokoyama N, Hyodo Y, Omura T, Yano I : A model-based pharmacokinetic analysis of drug-drug interaction between nirmatrelvir/ritonavir and tacrolimus, The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023), September 2023, Oslo．
Hori T, Yamamoto K, Ito T, Ikushima S, Itohara K, Kitahiro Y, Omura T, Yano I: Effect of early dose reduction of osimertinib on efficacy in the first-line treatment for EGFR-positive non-small cell lung cancer, 第33回日本医療薬学会年会,2023年11月,宮城
Enomoto D, Yamamoto K, Matsumoto Y, Morioka A, Omura T, Komatsu S, Yano Y, Fukumoto T, Takara K, Yano I: Impact of ALBI grade on lenvatinib treatment discontinuation due to adverse events in hepatocellular carcinoma patients, 第33回日本医療薬学会年会,2023年11月,宮城
Takahashi R, Itohara K, Nakagawa S, Katada Y, Sugimoto M, Umemura K, Matsumura K, Shigetsura Y, Imayoshi N, Katsube Y, Hira D, Tsuda M, Imai S, Yonezawa A, Nakagawa T, Tanaka S, Ohsumi A, Nakajima D, Nagao M, Date H, Terada T: Population pharmacokinetic analysis and dosing optimization of tacrolimus in lung transplant recipients with itraconazole, 第33回日本医療薬学会年会,2023年11月,宮城
Matsuda Y, Nakagawa S, Yano I, Masuda S, Imai S, Yonezawa A, Yamamoto T, Sugimoto M, Tsuda M, Tsuzuki T, Omura T, Nakagawa T, Chen-Yoshikawa TF, Nagao M, Date H, Matsubara K. Effect of itraconazole and its metabolite hydroxyitraconazole on the blood concentrations of cyclosporine and tacrolimus in lung transplant recipients. Biol Pharm Bull, 45 (4): 397-402 (2022)
Kunimitsu Y, Morio K, Hirata S, Yamamoto K, Omura T, Hara T, Harada K, Fujisawa M, Yano I. Effects of proton pump inhibitors on survival prognosis in patients with metastatic or unresectable urothelial carcinoma treated with pembrolizumab. Biol Pharm Bull, 45(5): 590-595 (2022)
Kakei Y, Ioroi T, Ito T, Okazaki Y, Hasegawa T, Yano I, Akashi M. Efficacy of ibuprofen gargle for postoperative pain after mandibular third molar extraction: protocol for a phase II, placebo-controlled, double-blind, randomized crossover trial. JMIR Res Protoc, 11(5): e35533 (2022)
Morio K, Kurata Y, Kawaguchi-Sakita N, Shiroshita A, Kataoka Y. Efficacy of Metformin in Patients with Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis. Ann Pharmacother, 56(3): 245-255 (2022)
Kimura T, Fujita M, Shimizu M, Sumiyoshi K, Bansho S, Yamamoto K, Omura T, Yano I. Effectiveness of pharmacist intervention for deprescribing potentially inappropriate medications: a prospective observational study. J Pharm Health Care Sci, 8:12 (2022)
Katada Y, Nakagawa S, Itohara K, Suzuki T, Kato R, Endo H, Sugimoto M, Yonezawa A, Nakagawa T, Ohsumi A, Nakajima D, Date H, Terada T. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation. J Pharm Health Care Sci, 8:25 (2022)
Takaichi M, Osawa K, Nomoto R, Nakanishi N, Kameoka M, Miura M, Shigemura K, Kinoshita S, Kitagawa K, Uda A, Miyara T, Mertaniasih NM, Hadi U, Raharjo D, Yulistiani R, Fujisawa K, Kuntaman K, Shirakawa T. Antibiotic resistance in non-typhoidal Salmonella enterica strains isolated from chicken meat in Indonesia. Pathogens, 11(5): 543 (2022)
Yamamoto K, Ioroi T, Shinomiya K, Yoshida A, Harada K, Fujisawa M, Omura T, Ikemi Y, Nakagawa S, Yonezawa A, Ogawa O, Matsubara K, Iwamoto T, Nishikawa K, Hayashi S, Tohara D, Murakami Y, Motoshima T, Jono H, Yano I. STAT3 polymorphism associates with mTOR inhibitor-induced interstitial lung disease in patients with renal cell carcinoma. Oncol Res, 29(1):11-23 (2022)
Yamamoto K, Nishiyama S, Kunisada M, Iida M, Ito T, Ioroi T, Makimoto H, Omura T, Harada K, Fujisawa M, Nishigori C, Yano I. Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II study (DGA study). Oncologist, 27(5): e384-e392 (2022)
Shigetsura Y, Imai S, Endo H, Shimizu Y, Ueda K, Murai T, Itohara K, Nakagawa S, Yonezawa A, Ikemi Y, Fukatsu S, Kitada N, Terada T, Nakagawa T, Matsubara K. Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder. Clin Neuropharmacol, 45(3): 52-60 (2022)
Masui S, Yonezawa A, Yokoyama K, Iwamoto N, Shimada T, Onishi A, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Nakagawa S, Hira D, Itohara K, Imai S, Nakagawa T, Hayakari M, Matsuda S, Morinobu A, Terada T, Matsubara K. N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4. Pharm Res, 39(10): 2541-2554 (2022)
Ogihara T, Kagawa M, Yamanaka R, Imai S, Itohara K, Hira D, Nakagawa S, Yonezawa A, Ito M, Nakagawa T, Terada T, Matsubara K. Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis. J Nat Med, 77(1): 53-63 (2022)
Itohara K, Yano I, Nakagawa S, Sugimoto M, Hirai M, Yonezawa A, Imai S, Nakagawa T, Hira D, Ito T, Hata K, Hatano E, Terada T, Matsubara K. Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics. Clin Transl Sci, 15(11): 2652-2662 (2022)
Ikuta K, Nakagawa S, Yamawaki C, Itohara K, Hira D, Imai S, Yonezawa A, Nakagawa T, Sakuragi M, Sato N, Uchino E, Yanagita M, Terada T. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study. BMC Nephrol, 23(1): 383 (2022)
Nakagawa S, Shimazaki A, Funakoshi T, Yonezawa A, Kataoka S, Horimatsu T, Hira D, Itohara K, Imai S, Nakagawa T, Matsubara T, Yanagita M, Muto M, Matsubara K, Terada T. Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration. Biol Pharm Bull, 46(2): 194-200 (2023)
Kitahiro Y, Ioroi K, Kakei Y, Yamashita J, Kimoto A, Hasegawa T, Morioka A, Yamamoto K, Akashi M, Yano I. Efficacy and Long-Term Safety of Ibuprofen Gargle for Oral Lichen Planus: A Study Protocol of Randomized Crossover and Long-Term Extension Trials. Methods Protoc, 6(7): 1-11 (2023)
Enomoto D, Yamamoto K, Matsumoto Y, Morioka A, Omura T, Komatsu S, Yano Y, Fukumoto T, Yano I. ALBI grade is a predictive factor of lenvatinib treatment discontinuation due to adverse events in hepatocellular carcinoma. Anticancer Res, 43(3): 1317-1323 (2023)
第10回（令和4年度）江口記念がん優秀論文賞：Yamamoto K, Nishiyama S, Kunisada M, Iida M, Ito T, Ioroi T, Makimoto H, Omura T, Harada K, Fujisawa M, Nishigori C, Yano I：Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot Skin Reaction: A Single-Arm, Open-Label Phase I/II study (DGA study) Oncologist, 27(5): e384-e392, 2022
Yamamoto K, Mahdy WYB, Ito T, Fujiwara N, Fujioka K, Horai T, Otsuka I, Imafuku H, Omura T, Iijima K, Yano I: Effects of pregnancy and renal ontogeny on risperidone/paliperidone pharmacokinetics predicted by physiologically based pharmacokinetic model, The 20th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2022), September 2022, Virtual.
Omura T, Nomura L, Nishiguchi H, Yamamoto K, Imai S, Nakagawa S, Itohara K, Yonezawa A, Nakagawa T, Yano I, Matsubara K.: Mir-101 regulates neuronal cell death by targeting suppressor/enhancer lin-12-like (SEL1L) in a cellular model of Parkinson’s disease using 6-hydorxydopamine, Neuroscience 2022, San Diego and Virtual, November 2022, USA, Virtual.
Fujimoto T, Ishimura T, Tashiro Y, Endo T, Nisioka S, Yokoyama N, Hyodo Y, Yamamoto K, Yano I, Fujisawa M: Association of ACTN3 polymorphism with Sarcopenia in Kidney Transplant Recipients, Transplantation Science Symposium Asian Regional Meeting 2022, November 2022, Kyoto.
Saito J, Nadatani N, Setoguchi M, Nakao M, Kimura H, Sameshima M, Kobayashi K, Matsumoto H, Yoshikawa N, Yokoyama T, Takahashi H, Suenaga M, Watanabe R, Imai K, Obara M, Hashimoto M, Yamamoto K, Fujiwara N, Sakata W, Nagai H, Enokihara T, Katayama S, Takahashi Y, Araki M, Iino K, Akiyama N, Katsu H, Fushimi K, Takeda T, Torimoto M, Kishi R, Mitsuya N, Kihara R, Hasegawa Y, Hamada Y, Kimura T, Wada M, Tanzawa A, Yamatani A. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan. J Pharm Health Care Sci, 7(1):23 (2021)
Koyanagi M, Imai S, Matsumoto M, Iguma Y, Kawaguchi-Sakita, N, Kotake T, Iwamitsu Y, Ntogwa M, Hiraiwa R, Nagayasu K, Saigo M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Nakagawa T, Matsubara K. Pro-nociceptive roles of Schwann cell-derived galectin-3 in taxane-induced peripheral neuropathy. Cancer Res, 81(8): 2207-2219 (2021)
Nakayama Y, Takara K, Minegaki T, Yamamoto K, Omura T, Yano I. Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells. Anticancer Res, 41(9):4239-4248 (2021)
Uda A, Shigemura K, Kitagawa K, Osawa K, Kusuki Mari, Yan Y, Yano I, Miyara T. Effect of Antimicrobial Stewardship on Oral Quinolone Use and Resistance Patterns over 8 Years (2013-2020). Antibiotics, 10(11):1426 (2021)
Itohara K, Yano I, Nakagawa S, Yonezawa A, Omura T, Imai S, Nakagawa T, Sawada A, Kobayashi T, Tochio A, Sakai K, Taura K, Ogawa O, Matsubara K. Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients. Drug Metab Pharmacokinet, 42(2):100423 (2022)
Ito T, Yamamoto K, Furukawa J, Harada K, Fujisawa M, Omura T, Yano I. Association of sunitinib concentration and clinical outcome in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule. J Clin Pharm Ther, 47(1):81-88 (2022)
Onishi R, Shigemura K, Osawa K, Yang Y, Maeda K, Fang S, Sung S, Onuma K, Uda A, Miyara T, Fujisawa M. The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing Escherichia coli. Antibiotics, 11(1):32 (2022)
Uda A, Ebisawa K, Sakon H, Kusuki M, Izuta R, Yahata M, Yano I, Miyara T. Sustained Improvements in Antimicrobial Therapy and Clinical Outcomes Following a Pharmacist-Led Antimicrobial Stewardship Intervention: Uncontrolled Before-After Study. J Clin Med, 11(3):566 (2022)
Uda A, Onuma K, Shigemura K, Kitagawa K, Yan Y, Osawa K, Yano I, Miyara T. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital. Antibiotics, 10(10):1247 (2022)
Omura T, Nomura L, Watanabe R, Nishiguchi H, Yamamoto K, Imai S, Nakagawa S, Itohara K, Yonezawa A, Nakagawa T, Kunimasa J, Yano I, Matsubara K. MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells. Front Mol Neurosci, 14(748026) (2022)
Uda A, Shigemura K, Kitagawa K, Osawa K, Onuma K, Yan Y, Fujisawa M, Yano I, Miyara T: Recent trend in oral quinolone use and emergence of anti-biotic resistant pathogens after intervention of antimicrobial stewardship program, The 1st International Electronic Conference on Antibiotics, May 2021, Virtual
Uda A, Kimura T, Kusuki M, Yano I, Miyara T: Evaluation of the clinical outcomes in patients with methi-cillin-susceptible Staphylococcus aureus bacteremia during a nationwide shortage of cefazolin, The 1st International Electronic Conference on Antibiotics, May 2021, Virtual
Mahdy WYB, Yamamoto K, Omura T, Yano I: Development of Physiologically Based Pharmacokinetic Model of Risperidone and Extrapolation to Different Ethnic Groups and Special Population, The CSPS/PSJ/CC-CRS 2021 Symposium, June 2021, Virtual
Uda A, Shibata K, Iida M, Yahata M, Izuta R, Yano I, Miyara T: Effect of infection control team-led intervention to promote compliance with hand hygiene practices in ward pharmacists, The 1st International Electronic Conference on Clinical Medicine, September 2021, Virtual
Uda A, Kimura T, Kusuki M, Izuta M, Yahata M, Yano I, Miyara T: Effectiveness of pharmacist-led appropriate antimicrobial therapy through the implementation of daily prospective audit and feedback and educational intervention, The 1st International Electronic Conference on Clinical Medicine, September 2021, Virtual
Mahdy WYB, Yamamoto K, Joji R, Hashimoto M, Nakasone R, Fujioka K, Omura T, Yano I: Development of a physiologically based pharmacokinetic model of fentanyl for preventing central toxicity in neonate patients on respiratory support, The 18th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2021), September 2021, Virtual
Yamamoto K, Joji R, Hashimoto M, Mahdy WYB, Nakasone R, Fujioka K, Omura T, Yano I: Association of serum fentanyl concentration and oxygen desaturation with oversedation in neonates, The 18th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2021), September 2021, Virtual
Hori T, Yamamoto K, Ito T, Ikushima S, Omura T, Yano I: Sequential Therapy from 1st or 2nd Generation EGFR-TKI to Osimertinib Lead to the Better Prognosis Compared to Prior Osimertinib therapy for Japanese Non Small-Cell Lung Cancer Patients with Exon 19 Deletions, The 5th International Cancer Research Symposium, January 2022, Virtual
Uda A, Ebisawa K, Kusuki M, Izuta R, Yahata M, Osawa K, Yano I, Miyara T: Impact of a multidisciplinary antimicrobial stewardship program for decreasing the duration of prophylactic antibiotic use，第31回日本医療薬学会年会，2021年10月，WEB開催
Ito T, Yamamoto K, Furukawa J, Harada K, Fujisawa M, Omura T, Yano I: Clinical significance of therapeutic drug monitoring of sunitinib in patients with metastatic renal cell carcinoma treated with a 2-week-on and 1-week-off schedule，第31回日本医療薬学会年会，2021年10月，WEB開催
谷藤亜希子：もう一度”医薬品の作用機序“を学びなおす，作用機序から考える糖尿病治療薬と骨粗鬆症治療薬の薬学的管理，2021年度神戸薬科大学エクステンションセンター生涯研修プログラム e-learning講座 第98回リカレントセミナー，2021年11月，WEB開催矢野育子：ポリファーマシーに対する入院を契機とした薬剤師の介入，Pharmacist Web Seminar in 北摂，2021年12月，WEB開催
Jin C, Yonezawa A, Yoshimatsu H, Imai S, Koyanagi M, Yamanishi K, Nakagawa S, Itohara K, Omura T, Nakagawa T, Nagai J, Matsubara K. Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice. Sci Rep, 10(1):18443 (2020)
Ioroi T, Kiyota N, Imamura Y, Tanda M, Aoki S, Okuno M, Yamamoto K, Sasaki R, Nibu K, Minami H, Hirai M, Yano I. Ibuprofen Gargle for Chemo- or Chemoradiotherapy-Induced Oral Mucositis: A Feasibility Study. J Pharm Health Care Sci, 6:12 (2020)
Yamashita K, Ogihara T, Hayashi M, Nakagawa T, Ishizaki Y, Kume M, Yano I, Niigata R, Hiraoka J, Yasui H, Nakamura T. Association between dexamethasone treatment and alterations in serum concentrations of trace metals. Pharmazie, 75(5): 218-222 (2020)
Ito T, Yamamoto K, Ogawa S, Furukawa J, Harada K, Fujisawa M, Omura T, Yano I. Model-based assessment of pharmacokinetic changes of sunitinib, tacrolimus, and everolimus in a patient with metastatic renal cell carcinoma after renal transplantation. Drug Metab Pharmacokinet, 35(5):405-409 (2020)
Kondo M, Nakagawa S, Orii S, Itohara K, Sugimoto M, Omura T, Sato Y, Imai S, Yonezawa A, Nakagawa T, Matsubara K. Share Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram- Positive Bacterial Infection. Biol Pharm Bull. 43(10):1463-1468 (2020)
Ntogwa M, Imai S, Hiraiwa R, Koyanagi M, Matsumoto M, Ogihara T, Nakagawa S, Omura T, Yonezawa A, Nakagawa T, Matsubara K. Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice. Brain Behav Immun, 88:325- 339 (2020)
Kusumoto J, Uda A, Kimura T, Furudoi S, Yoshii R, Matsumura M, Miyara T, Akashi
M. Effect of educational intervention on the appropriate use of oral antimicrobials in oral and maxillofacial surgery: a retrospective secondary data analysis. BMC Oral Health, 21(1):20 (2021)
Uda A, Shigemura K, Kitagawa K, Osawa K, Onuma K, Yan Y, Nakano Y, Nishioka T, Fujisawa M, Yano I, Miyara T. Risk Factors for the Acquisition of Enterococcus faecium Infection and Mortality in Patients with Enterococcal Bacteremia: A 5-year Retrospective Analysis in a Tertiary Care University Hospital. Antibiotics, 10(1)E64, (2021)
Yamamoto J, Omura T, Kasamo S, Yamamoto S, Kawata M, Yonezawa A, Taruno Y, Endo H, Aizawa H, Sawamoto N, Matsubara K, Takahashi R, Tasaki Y. Impact of the catechol-O-methyltransferase Val158Met polymorphism on the pharmacokinetics of L-dopa and its metabolite 3-O-methyldopa in combination with entacapone. J Neural Transm (Vienna) , 128(1):27-36 (2021)
Morio K, Yamamoto K, Yano I. Relationship Between Tramadol Response and Cancer Cachexia: A Retrospective Cohort Study. Am J Hosp Palliat Care, 38(3):276- 282 (2021)
Yoshida A, Yamamoto K, Ishida T, Omura T, Itoh T, Nishigori C, Sakane T, Yano I. Sunitinib decreases the expression of KRT6A and SERPINB1 in 3D human epidermal models. Exp Dermatol, 30(3):337-346 (2021)
Doi H, Matsumoto M, Tsunogi M, Kadono S, Tanda M, Watanabe M, Goto H, Kurata K, Miyata Y, Kitao A, Kosaka Y, Yakushijin K: The status and innovations of HSCT medical practitioners in the COVID-19 pandemic in HYOGO, JAPAN. The 25th Annual Congress of the Asia-Pacific Blood and Marrow Transplantation Group 2020. October 2020, Virtual
Yoshida A, Yamamoto K, Ishida T, Omura T, Itoh T, Nishigori C, Sakane T, Yano I: Impact of sunitinib on the expression of cornifying factors in human epidermal 3D skin models, The 4th International Cancer Research Symposium of Training Plan for Oncology Professionals, February 2021, Virtual
Yamamoto J, Omura T, Kasamo S, Yamamoto S, Kawata M, Yonezawa A, Taruno Y, Endo H, Aizawa H, Sawamoto N, Matsubara K, Takahashi R, Tasaki Y: POLYMORPHISM OF CATECHOL-O-METHYLTRANSFERASE CHANGES PLASMA CONCENTRATION OF L-DOPA AND 3-O-METHYLDOPA, 15th International Conference on Alzheimer’s and Parkinson’s Diseases, March 2021, Virtual
Uda A, Shigemura K, Kitagawa K, Osawa K, Onuma K, Inoue S, Kotani J, Yan Y, Nakano Y, Nishioka T, Miyara T, Fujisawa M, Yano I: Effects of pharmacist-led antimicrobial stewardship programme in urological patients, 第 30 回日本医療薬学会年会，2020 年 10 月，WEB 開催
Ueda R, Tanda M, Ito T, Enomoto A, Iida M, Mizuta N, Yamamoto K, Makimoto H, Omura T, Yano I Ueda R, Tanda M, Ito T, Enomoto A, Iida M, Mizuta N, Yamamoto K, Makimoto H, Omura T, Yano I: Reinforced collaboration between community pharmacies and hospital for the management of oral anti-cancer therapy using information sharing tools and team-based learning, 第 30 回日本医療薬学会年会，2020 年 10 月，WEB 開催
